PURE RX Trademark

Trademark Overview

On Sunday, August 3, 2025, a trademark application was filed for PURE RX with the United States Patent and Trademark Office. The USPTO has given the PURE RX trademark a serial number of 99295624. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 12, 2026. This trademark is owned by Pure Rx LLC. The PURE RX trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacturing of pharmaceuticals
pure rx

General Information

Serial Number99295624
Word MarkPURE RX
Filing DateSunday, August 3, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 12, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2026

Trademark Statements

Goods and ServicesCustom manufacturing of pharmaceuticals
NOT AVAILABLERX

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateSunday, August 3, 2025
Primary Code040
First Use Anywhere DateFriday, January 1, 2021
First Use In Commerce DateFriday, January 1, 2021

Trademark Owner History

Party NamePure Rx LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60611
US
Party NamePure Rx LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60611
US

Trademark Events

Event DateEvent Description
Sunday, August 3, 2025NEW APPLICATION ENTERED
Sunday, August 3, 2025APPLICATION FILING RECEIPT MAILED
Thursday, November 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 17, 2025ASSIGNED TO EXAMINER
Friday, December 19, 2025NON-FINAL ACTION WRITTEN
Friday, December 19, 2025NON-FINAL ACTION E-MAILED
Friday, December 19, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 6, 2026ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, April 6, 2026ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, April 15, 2026TEAS PETITION TO REVIVE RECEIVED
Wednesday, April 15, 2026PETITION TO REVIVE-GRANTED
Wednesday, April 15, 2026NOTICE OF REVIVAL - E-MAILED
Wednesday, April 15, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 15, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 15, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 17, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 6, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 12, 2026PUBLISHED FOR OPPOSITION
Tuesday, May 12, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

pure pharmaceuticals manufacturing custom